Sanofi quarter change: USA Bonds: Other Debt, Unchanged
In other debt filed by principal amount (debentures, bonds) (listed in the US), from the quarter ended 2026-03-31 to 2026-06-30, Sanofi opened 0 positions, added to 0, reduced 0, sold out of 0 and left 0 unchanged.
Two Form 13F-HR filings compared (SEC CIK 1121404): 2026-03-31 (filed 2026-05-07) and 2026-06-30 (filed 2026-07-28). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.
No position of this class changed this way between the two filings.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Leeward Financial Partners, LLC | United States | $0.336B | 97 |
| Haverford Financial Services, Inc. | United States | $0.336B | 46 |
| WT Wealth Management | United States | $0.336B | 138 |
| Standard General L.P. | United States | $0.336B | 2 |
| Team Hewins, LLC | United States | $0.337B | 41 |
| Kooman & Associates | United States | $0.335B | 51 |
| Comprehensive Financial Consultants Institutional, Inc. | United States | $0.337B | 193 |
| Independent Wealth Network Inc. | United States | $0.337B | 301 |
| Schiavi & Co LLC | United States | $0.337B | 51 |
| Hudson Value Partners, LLC | United States | $0.335B | 101 |